- Pharmaceutical Products
- Glands And Other Organs For Organo-therapeutic Uses, Dried, Whether Or Not Powdered; Extracts Of Glands Or Other Organs Or Of Their Secretions For Organo-therapeutic Uses; Heparin And Its Salts; Other Human Or Animal Substances Prepared For Therapeutic Or Prophylactic Uses, Not Elsewhere Specified Or Included.
- Extracts Of Glands Or Other Organs Or Of Their Secretions, For Organo-therapeutic Uses
Tetracaine Hydrochloride
Product Images
Product Property
Product Status : | New |
Sample Available : | yes |
Shipment Terms : | fob |
Payment Mode : |
T/T,WesternUnion,MoneyGram |
Description
Product Description
Quick Details
Alias: Tetracaine hydrochloride , 2-Dimethylaminoethyl 4-n-butylaminobenzoate hydrochloride;4-(Butylamino)benzoic acid
CAS NO.: 136-47-0
EINECS: 205-248-5
MF: C15H25ClN2O2
MW: 300.82
Melting point: 149°C
Assay: 99%
Grade: Pharmaceutical Grade
Storage: Closed, confined and shading preservation
Manufacturer: Simeiquan
Usage: Local anesthetic; Mainly used in mucosa anesthetic. The function is stronger than Procaine and Lidocaine.
Description:
Tetracaine HCl is synthesized from 4-butylaminobenzoic acid. The ethyl ester is formed through an acid-catalyzed esterification reaction. Base-catalyzed transesterification is achieved by boiling the ethyl ester of 4-butylaminobenzoic acid with excess 2-dimethylaminoethanol in the presence of a small amount of sodium ethoxide.
Application:
Tetracaine (INN, also known as amethocaine; trade name Pontocaine. Ametop and Dicaine) is a potent local anesthetic of the ester group. It is mainly used topically in ophthalmology and as an antipruritic, and it has been used in spinal anesthesia.
In biomedical research, tetracaine is used to alter the function of calcium release channels (ryanodine receptors) that control the release of calcium from intracellular stores. Tetracaine is an allosteric blocker of channel function. At low concentrations, tetracaine causes an initial inhibition of spontaneous calcium release events, while at high concentrations, tetracaine blocks release completely.
Email:sales09 at ycphar dom com
Skype:sales09_109
Telephone:86-027-50756084
Quick Details
Alias: Tetracaine hydrochloride , 2-Dimethylaminoethyl 4-n-butylaminobenzoate hydrochloride;4-(Butylamino)benzoic acid
CAS NO.: 136-47-0
EINECS: 205-248-5
MF: C15H25ClN2O2
MW: 300.82
Melting point: 149°C
Assay: 99%
Grade: Pharmaceutical Grade
Storage: Closed, confined and shading preservation
Manufacturer: Simeiquan
Usage: Local anesthetic; Mainly used in mucosa anesthetic. The function is stronger than Procaine and Lidocaine.
Description:
Tetracaine HCl is synthesized from 4-butylaminobenzoic acid. The ethyl ester is formed through an acid-catalyzed esterification reaction. Base-catalyzed transesterification is achieved by boiling the ethyl ester of 4-butylaminobenzoic acid with excess 2-dimethylaminoethanol in the presence of a small amount of sodium ethoxide.
Application:
Tetracaine (INN, also known as amethocaine; trade name Pontocaine. Ametop and Dicaine) is a potent local anesthetic of the ester group. It is mainly used topically in ophthalmology and as an antipruritic, and it has been used in spinal anesthesia.
In biomedical research, tetracaine is used to alter the function of calcium release channels (ryanodine receptors) that control the release of calcium from intracellular stores. Tetracaine is an allosteric blocker of channel function. At low concentrations, tetracaine causes an initial inhibition of spontaneous calcium release events, while at high concentrations, tetracaine blocks release completely.
Email:sales09 at ycphar dom com
Skype:sales09_109
Telephone:86-027-50756084